Insider Trading activities of Momenta Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Momenta Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Momenta Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Momenta Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is MNTA. The reporting company's CIK number is 1235010.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $75,395,716.
The total value of stock option exercises since 2005 is $11,001,864.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Momenta Pharmaceuticals Inc (MNTA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-09 0 $0 50,284 $927,053 39,834 $295,169
2017-08 0 $0 29,379 $485,260 11,500 $85,215
2017-05 0 $0 8,379 $131,824 0 $0
2017-02 0 $0 7,745 $120,315 0 $0
2017-01 0 $0 5,000 $90,000 39,647 $400,831
2016-12 0 $0 11,250 $168,750 0 $0
2016-11 0 $0 10,020 $136,995 0 $0
2016-08 0 $0 10,022 $120,624 0 $0
2016-06 0 $0 5,200 $67,600 5,200 $67,080
2016-05 0 $0 10,779 $109,954 0 $0
2016-04 0 $0 2,843 $27,207 0 $0
2016-02 0 $0 46,175 $282,126 0 $0
2015-12 0 $0 520 $8,236 0 $0
2015-11 0 $0 62,972 $1,132,339 41,667 $674,172
2015-09 0 $0 513 $9,705 0 $0
2015-08 0 $0 47,054 $1,041,049 20,000 $344,600
2015-07 0 $0 4,570 $102,139 6,667 $52,135
2015-06 0 $0 426,432 $9,865,529 364,920 $5,303,773
2015-05 0 $0 83,050 $1,679,725 72,025 $944,107
2015-04 0 $0 194,846 $3,797,208 131,667 $1,649,472
2015-03 0 $0 46,969 $704,358 0 $0
2015-02 0 $0 25,184 $330,296 10,000 $88,500
2015-01 0 $0 0 $0 11,250 $77,400
2014-12 0 $0 17,750 $214,695 25,000 $172,000
2014-11 0 $0 11,267 $127,211 0 $0
2014-10 0 $0 3,723 $44,676 5,000 $44,250
2014-09 0 $0 3,640 $41,568 0 $0
2014-08 0 $0 16,810 $197,696 0 $0
2014-05 0 $0 9,105 $107,168 0 $0
2014-04 0 $0 485 $5,218 0 $0
2014-03 0 $0 64 $922 31,200 $153,192
2014-02 0 $0 53,764 $960,447 12,800 $62,848
2014-01 0 $0 27,159 $529,600 0 $0
2013-11 0 $0 56,017 $997,222 0 $0
2013-10 0 $0 5,247 $81,118 0 $0
2013-08 0 $0 9,432 $140,663 0 $0
2013-07 0 $0 30,000 $498,300 0 $0
2013-06 0 $0 32,072 $468,571 0 $0
2013-05 0 $0 9,107 $118,854 0 $0
2013-03 0 $0 31,440 $444,570 0 $0
2013-02 0 $0 20,058 $247,976 0 $0
2012-12 0 $0 0 $0 7,200 $7,128
2012-11 0 $0 9,292 $99,303 0 $0
2012-10 0 $0 1,000 $14,530 0 $0
2012-08 0 $0 20,675 $286,224 0 $0
2012-07 0 $0 1,600 $22,592 0 $0
2012-06 0 $0 1,420 $20,216 46,728 $28,504
2012-05 0 $0 11,790 $164,655 0 $0
2012-04 0 $0 17,000 $257,280 0 $0
2012-03 0 $0 2,000 $30,060 0 $0
2012-02 0 $0 23,946 $367,917 0 $0
2012-01 0 $0 2,000 $38,780 0 $0
2011-12 0 $0 2,426 $37,601 3,000 $42,270
2011-11 0 $0 14,016 $208,254 0 $0
2011-10 0 $0 2,000 $24,660 0 $0
2011-09 0 $0 3,746 $61,963 0 $0
2011-08 0 $0 13,125 $210,321 0 $0
2011-07 0 $0 28,787 $587,534 0 $0
2011-06 0 $0 26,629 $536,069 0 $0
2011-05 0 $0 33,827 $649,165 0 $0
2011-04 0 $0 9,034 $163,241 0 $0
2011-03 0 $0 6,493 $92,272 0 $0
2011-02 0 $0 27,696 $372,128 7,000 $86,380
2010-12 0 $0 127,350 $1,847,704 64,000 $14,784
2010-11 0 $0 9,118 $139,199 0 $0
2010-10 0 $0 0 $0 55,730 $12,873
2010-09 0 $0 15,852 $238,894 0 $0
2010-08 0 $0 218,752 $4,085,767 0 $0
2010-07 0 $0 202,950 $4,400,886 0 $0
2010-06 0 $0 3,353 $49,007 0 $0
2010-05 0 $0 13,639 $169,453 0 $0
2010-04 0 $0 0 $0 35,200 $103,840
2010-03 0 $0 77,598 $1,163,102 32,000 $7,392
2010-02 0 $0 15,388 $229,155 0 $0
2010-01 0 $0 42,483 $637,145 0 $0
2009-12 0 $0 677 $7,528 0 $0
2009-11 0 $0 4,668 $50,250 0 $0
2009-09 0 $0 673 $6,987 0 $0
2009-08 0 $0 5,100 $50,361 0 $0
2009-06 0 $0 677 $6,157 0 $0
2009-05 0 $0 3,096 $26,460 0 $0
2009-03 0 $0 633 $5,527 0 $0
2009-02 0 $0 11,655 $124,328 0 $0
2009-01 0 $0 9,495 $113,940 0 $0
2008-12 0 $0 12,380 $146,060 0 $0
2008-11 0 $0 371 $2,882 0 $0
2008-08 0 $0 48,540 $849,716 0 $0
2008-06 0 $0 335 $4,440 0 $0
2008-04 0 $0 9,375 $121,875 0 $0
2008-03 0 $0 375 $3,449 0 $0
2007-12 0 $0 1,500 $10,770 0 $0
2007-10 0 $0 10,000 $125,972 0 $0
2007-09 0 $0 10,000 $111,750 0 $0
2007-08 0 $0 10,000 $105,050 0 $0
2007-07 0 $0 10,000 $104,400 0 $0
2007-06 0 $0 10,000 $121,250 0 $0
2007-05 0 $0 10,000 $120,660 0 $0
2007-04 0 $0 16,666 $246,290 0 $0
2007-03 0 $0 10,000 $123,370 0 $0
2007-02 0 $0 21,250 $376,800 11,250 $94,612
2007-01 0 $0 93,666 $1,587,741 0 $0
2006-12 0 $0 136,166 $2,299,821 0 $0
2006-11 0 $0 142,166 $2,276,913 0 $0
2006-10 0 $0 86,254 $1,287,385 0 $0
2006-09 0 $0 258,976 $3,931,187 0 $0
2006-08 0 $0 370,088 $6,015,083 0 $0
2006-07 0 $0 21,500 $274,560 1,500 $12,150
2006-06 0 $0 10,000 $139,400 0 $0
2006-05 0 $0 45,821 $706,544 0 $0
2006-04 0 $0 165,700 $2,811,520 0 $0
2006-03 0 $0 3,383 $82,545 0 $0
2006-02 0 $0 81,706 $2,000,715 21,875 $177,187
2005-12 0 $0 22,000 $536,926 0 $0
2005-11 0 $0 22,000 $463,900 0 $0
2005-10 0 $0 22,000 $590,448 0 $0
2005-09 0 $0 22,200 $596,728 0 $0
2005-08 0 $0 22,000 $509,780 0 $0
2005-07 0 $0 22,000 $491,596 0 $0
2005-06 0 $0 89,500 $1,213,204 0 $0
2005-05 0 $0 90,500 $843,604 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Momenta Pharmaceuticals Inc insiders (MNTA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-09-28 Wheeler Craig A (President) Sale 35,667 19.02 678,564
2017-09-28 Wheeler Craig A (President) Option Ex 25,667 7.41 190,192
2017-09-01 Wheeler Craig A (President) Sale 14,617 17.00 248,489
2017-09-01 Wheeler Craig A (President) Option Ex 14,167 7.41 104,977
2017-08-31 Wheeler Craig A (President) Sale 5,750 17.00 97,750
2017-08-31 Wheeler Craig A (President) Option Ex 2,300 7.41 17,043
2017-08-21 Leicher Bruce (SVP & General Counsel) Sale 802 15.20 12,190
2017-08-21 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 821 15.20 12,479
2017-08-21 Wheeler Craig A (President) Sale 4,116 15.06 62,007
2017-08-10 Leicher Bruce (SVP & General Counsel) Sale 350 16.60 5,810
2017-08-10 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 387 16.60 6,424
2017-08-10 Wheeler Craig A (President) Sale 16,953 16.82 285,200
2017-08-10 Wheeler Craig A (President) Option Ex 9,100 7.41 67,431
2017-08-02 Wheeler Craig A (President) Sale 200 17.00 3,400
2017-08-02 Wheeler Craig A (President) Option Ex 100 7.41 741
2017-05-22 Leicher Bruce (SVP & General Counsel) Sale 859 14.80 12,713
2017-05-19 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 821 15.90 13,053
2017-05-19 Wheeler Craig A (President) Sale 4,116 15.83 65,156
2017-05-10 Leicher Bruce (SVP & General Counsel) Sale 347 16.00 5,552
2017-05-10 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 384 16.00 6,144
2017-05-10 Wheeler Craig A (President) Sale 1,852 15.77 29,206
2017-02-22 Leicher Bruce (SVP & General Counsel) Sale 1,050 15.60 16,380
2017-02-22 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 1,069 15.60 16,676
2017-02-22 Wheeler Craig A (President) Sale 5,626 15.51 87,259
2017-01-31 Leicher Bruce (SVP & General Counsel) Sale 5,000 18.00 90,000
2017-01-09 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Option Ex 39,647 10.11 400,831
2016-12-15 Shea Richard P (SVP, CFO) Sale 9,799 15.00 146,985
2016-12-09 Shea Richard P (SVP, CFO) Sale 1,451 15.00 21,765
2016-11-22 Roach James M. (Senior VP, Development and Chi) Sale 250 14.40 3,600
2016-11-22 Leicher Bruce (SVP & General Counsel) Sale 227 14.40 3,268
2016-11-22 Shea Richard P (SVP, CFO) Sale 227 14.40 3,268
2016-11-22 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 227 14.40 3,268
2016-11-22 Wheeler Craig A (President) Sale 1,764 14.05 24,784
2016-11-21 Roach James M. (Senior VP, Development and Chi) Sale 841 13.45 11,311
2016-11-21 Leicher Bruce (SVP & General Counsel) Sale 803 13.45 10,800
2016-11-21 Shea Richard P (SVP, CFO) Sale 744 13.45 10,006
2016-11-21 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 821 13.45 11,042
2016-11-21 Wheeler Craig A (President) Sale 4,116 13.52 55,648
2016-08-22 Roach James M. (Senior VP, Development and Chi) Sale 249 12.10 3,012
2016-08-22 Leicher Bruce (SVP & General Counsel) Sale 227 12.10 2,746
2016-08-22 Shea Richard P (SVP, CFO) Sale 227 12.10 2,746
2016-08-22 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 227 12.10 2,746
2016-08-22 Wheeler Craig A (President) Sale 1,764 12.00 21,168
2016-08-19 Roach James M. (Senior VP, Development and Chi) Sale 842 12.04 10,137
2016-08-19 Leicher Bruce (SVP & General Counsel) Sale 803 12.04 9,668
2016-08-19 Shea Richard P (SVP, CFO) Sale 745 12.04 8,969
2016-08-19 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 822 12.04 9,896
2016-08-19 Wheeler Craig A (President) Sale 4,116 12.04 49,536
2016-06-01 Shapiro Bennett M Sale 5,200 13.00 67,600
2016-06-01 Shapiro Bennett M Option Ex 5,200 12.90 67,080
2016-05-20 Roach James M. (Senior VP, Development and Chi) Sale 250 10.11 2,527
2016-05-20 Leicher Bruce (SVP & General Counsel) Sale 1,000 10.40 10,400
2016-05-20 Shea Richard P (SVP, CFO) Sale 227 10.11 2,294
2016-05-20 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 227 10.11 2,294
2016-05-20 Wheeler Craig A (President) Sale 1,764 10.13 17,869
2016-05-19 Roach James M. (Senior VP, Development and Chi) Sale 842 10.20 8,588
2016-05-19 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 784 10.20 7,996
2016-05-19 Shea Richard P (SVP, CFO) Sale 746 10.20 7,609
2016-05-19 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 823 10.20 8,394
2016-05-19 Wheeler Craig A (President) Sale 4,116 10.20 41,983
2016-04-19 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 2,843 9.57 27,207
2016-02-23 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 102 9.80 999
2016-02-22 Roach James M. (Senior VP, Development and Chi) Sale 250 9.65 2,412
2016-02-22 Leicher Bruce (SVP & General Counsel) Sale 227 9.65 2,190
2016-02-22 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 1,095 9.68 10,618
2016-02-22 Shea Richard P (SVP, CFO) Sale 227 9.65 2,190
2016-02-22 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 227 9.65 2,190
2016-02-22 Wheeler Craig A (President) Sale 1,688 9.95 16,795
2016-02-19 Roach James M. (Senior VP, Development and Chi) Sale 2,158 9.64 20,813
2016-02-19 Leicher Bruce (SVP & General Counsel) Sale 2,000 9.64 19,290
2016-02-19 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 2,065 9.63 19,913
2016-02-19 Shea Richard P (SVP, CFO) Sale 1,823 9.64 17,582
2016-02-19 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 2,138 9.64 20,621
2016-02-19 Wheeler Craig A (President) Sale 9,844 9.36 92,139
2016-02-18 Roach James M. (Senior VP, Development and Chi) Sale 272 10.49 2,853
2016-02-18 Leicher Bruce (SVP & General Counsel) Sale 337 10.49 3,535
2016-02-18 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 272 10.49 2,853
2016-02-18 Shea Richard P (SVP, CFO) Sale 183 10.49 1,919
2016-02-18 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 272 10.49 2,853
2016-02-17 Wheeler Craig A (President) Sale 1,688 11.30 19,074
2016-02-09 Roach James M. (Senior VP, Development and Chi) Sale 17,100 .00 0
2015-12-11 Franken Michael (President, Biosimilars Busines) Sale 520 15.84 8,236
2015-11-23 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 80 17.91 1,432
2015-11-20 Roach James M. (Senior VP, Development and Chi) Sale 360 17.75 6,390
2015-11-20 Leicher Bruce (SVP & General Counsel) Sale 328 17.75 5,822
2015-11-20 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 468 17.75 8,307
2015-11-20 Shea Richard P (SVP, CFO) Sale 227 17.75 4,029
2015-11-20 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 227 17.75 4,029
2015-11-20 Wheeler Craig A (President) Sale 1,766 17.86 31,540
2015-11-19 Roach James M. (Senior VP, Development and Chi) Sale 603 18.17 10,956
2015-11-19 Leicher Bruce (SVP & General Counsel) Sale 603 18.17 10,956
2015-11-19 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 574 18.17 10,429
2015-11-19 Shea Richard P (SVP, CFO) Sale 397 18.17 7,213
2015-11-19 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 397 18.17 7,213
2015-11-19 Wheeler Craig A (President) Sale 2,061 18.05 37,201
2015-11-18 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 76 17.70 1,345
2015-11-17 Roach James M. (Senior VP, Development and Chi) Sale 312 17.65 5,506
2015-11-17 Leicher Bruce (SVP & General Counsel) Sale 387 17.65 6,830
2015-11-17 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 312 17.65 5,506
2015-11-17 Shea Richard P (SVP, CFO) Sale 145 17.65 2,559
2015-11-17 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 216 17.65 3,812
2015-11-17 Wheeler Craig A (President) Sale 1,766 17.70 31,258
2015-11-05 Wheeler Craig A (President) Sale 51,667 18.00 930,006
2015-11-05 Wheeler Craig A (President) Option Ex 41,667 16.18 674,172
2015-09-11 Franken Michael (President, Biosimilars Busines) Sale 513 18.92 9,705
2015-08-21 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 79 20.01 1,580
2015-08-20 Roach James M. (Senior VP, Development and Chi) Sale 363 22.20 8,058
2015-08-20 Leicher Bruce (SVP & General Counsel) Sale 330 22.20 7,326
2015-08-20 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 470 22.20 10,434
2015-08-20 Shea Richard P (SVP, CFO) Sale 228 22.20 5,061
2015-08-20 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 228 22.20 5,061
2015-08-20 Wheeler Craig A (President) Sale 1,766 22.28 39,346
2015-08-19 Roach James M. (Senior VP, Development and Chi) Sale 7,011 22.05 154,592
2015-08-19 Leicher Bruce (SVP & General Counsel) Sale 601 22.00 13,222
2015-08-19 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 573 22.00 12,606
2015-08-19 Shea Richard P (SVP, CFO) Sale 396 22.00 8,712
2015-08-19 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 396 22.00 8,712
2015-08-19 Wheeler Craig A (President) Sale 2,061 22.02 45,383
2015-08-18 Roach James M. (Senior VP, Development and Chi) Sale 6,500 21.81 141,765
2015-08-18 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 2,916 21.90 63,860
2015-08-17 Roach James M. (Senior VP, Development and Chi) Sale 312 21.67 6,761
2015-08-17 Leicher Bruce (SVP & General Counsel) Sale 386 21.67 8,364
2015-08-17 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 312 21.67 6,761
2015-08-17 Shea Richard P (SVP, CFO) Sale 144 21.67 3,120
2015-08-17 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 216 21.67 4,680
2015-08-17 Wheeler Craig A (President) Sale 1,766 21.77 38,445
2015-08-10 Franken Michael (President, Biosimilars Busines) Sale 20,000 22.36 447,200
2015-08-10 Franken Michael (President, Biosimilars Busines) Option Ex 20,000 17.23 344,600
2015-07-15 Stoner Elizabeth Sale 4,570 22.35 102,139
2015-07-15 Stoner Elizabeth Option Ex 6,667 7.82 52,135
2015-06-19 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 21,274 25.50 542,487
2015-06-19 Bishop John E (Senior VP, Pharmaceutical Scie) Option Ex 21,274 15.44 328,470
2015-06-18 Roach James M. (Senior VP, Development and Chi) Sale 25,000 23.70 592,500
2015-06-18 Roach James M. (Senior VP, Development and Chi) Option Ex 25,000 7.41 185,250
2015-06-18 Leicher Bruce (SVP & General Counsel) Sale 20,000 23.00 460,000
2015-06-18 Leicher Bruce (SVP & General Counsel) Option Ex 20,000 15.12 302,400
2015-06-18 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 35,529 23.63 839,656
2015-06-18 Bishop John E (Senior VP, Pharmaceutical Scie) Option Ex 24,529 12.92 316,914
2015-06-18 Wheeler Craig A (President) Sale 155,000 24.16 3,745,575
2015-06-18 Wheeler Craig A (President) Option Ex 125,000 16.18 2,022,500
2015-06-17 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 784 23.00 18,032
2015-06-17 Bishop John E (Senior VP, Pharmaceutical Scie) Option Ex 784 12.58 9,862
2015-06-11 Franken Michael (President, Biosimilars Busines) Sale 512 22.37 11,453
2015-06-04 Wheeler Craig A (President) Sale 103,333 22.00 2,273,326
2015-06-04 Wheeler Craig A (President) Option Ex 83,333 16.18 1,348,327
2015-06-01 Roach James M. (Senior VP, Development and Chi) Sale 25,000 21.70 542,500
2015-06-01 Roach James M. (Senior VP, Development and Chi) Option Ex 25,000 7.41 185,250
2015-06-01 Leicher Bruce (SVP & General Counsel) Sale 40,000 21.00 840,000
2015-06-01 Leicher Bruce (SVP & General Counsel) Option Ex 40,000 15.12 604,800
2015-05-26 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 254 19.80 5,029

Insider trading activities including stock purchases, stock sales, and option exercises of MNTA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Momenta Pharmaceuticals Inc (symbol MNTA, CIK number 1235010) see the Securities and Exchange Commission (SEC) website.